1.
A structurally guided dissection-then-evolution strategy for ligan..
[3278]
|
2.
Cryo-EM structures of orphan GPR21 signaling complexes
[1699]
|
3.
Crystal structure of a multi-domain human smoothened receptor in c..
[1678]
|
4.
Cryo-EM structure of constitutively active human Frizzled 7 in com..
[1292]
|
5.
The activation mechanism and antibody binding mode for orphan GPR2..
[1235]
|
6.
Crystal structure of the Frizzled 4 receptor in a ligand-free stat..
[1145]
|
7.
Determination of an underneath binding in the transmembrane domain..
[1098]
|
8.
Colocalization Strategy Unveils an Underside Binding Site in the T..
[1097]
|
9.
Multiregional profiling of the brain transmembrane proteome uncove..
[923]
|
10.
The structure-based traceless specific fluorescence labeling of th..
[874]
|
11.
Elucidation of Distinct Modular Assemblies of Smoothened Receptor ..
[867]
|
12.
Structural Basis for Apelin Control of the Human Apelin Receptor
[858]
|
13.
Structural insight into apelin receptor-G protein stoichiometry
[788]
|
14.
Structural basis of ligand recognition and self-activation of orph..
[766]
|
15.
一种卷曲受体7的小分子抑制剂及其制备方法和应用
[670]
|
16.
Structure-Based Ligand Discovery Targeting the Transmembrane Domai..
[658]
|
17.
Structure-Activity Relationship Studies of Hydantoin-Cored Ligands..
[653]
|
18.
The importance of ligands for G protein-coupled receptor stability
[644]
|
19.
一种FZD7鼠源单克隆抗体及其制备方法和应用
[618]
|
20.
Toward the first orphan GPCR structure
[600]
|
21.
Cryo-EM structure of human kappa-opioid receptor-G(i) complex boun..
[592]
|
22.
平滑受体配体及其应用
[573]
|
23.
Structural and Druggability Landscape of Frizzled G Protein-Couple..
[566]
|
24.
孤儿受体GPR52晶体结构揭示配体结合新机制
[535]
|
25.
Structural insights into the lipid and ligand regulation of a huma..
[530]
|
26.
The versatile binding landscape of the TAAR1 pocket for LSD and ot..
[521]
|
27.
Molecular recognition of the atypical chemokine-like peptide GPR15..
[518]
|
28.
Apj(+) Vessels Drive Tumor Growth and Represent a Tractable Therap..
[506]
|
29.
The binding mechanism of an anti-multiple myeloma antibody to the ..
[485]
|
30.
Structural Mass Spectrometry Captures Residue-Resolved Comprehensi..
[474]
|
31.
Structural basis of Frizzled 4 in recognition of Dishevelled 2 unv..
[453]
|
32.
Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Ty..
[418]
|
33.
A framework for Frizzled-G protein coupling and implications to th..
[417]
|
34.
Nonlinear relationship between body mass index and serum uric acid..
[412]
|
35.
Association between glycemia risk index and arterial stiffness in ..
[380]
|
36.
Unveiling the structural mechanisms of nonpeptide ligand recognit..
[337]
|
37.
人源Apelin受体与天然配体Apelin的多肽类似物的复合物晶体结构
[330]
|
38.
Crystal structure of the first orphan GPCR
[325]
|
39.
强啡肽单抗融合蛋白的克隆、表达及功能分析
[309]
|
40.
Structural insights into the regulation of monomeric and dimeric a..
[208]
|
41.
靶向FZD7的单克隆抗体及其制备方法和用途
[80]
|
42.
Antagonist E7 Acts As an Intracellular Covalent Ligand of Orphan R..
[58]
|
43.
Association of iodized salt intake with the risk of physical frail..
[43]
|